cetuximab
eli lilly
['cetuximab', 'cisplatin']
dr jolie ringash:
phase 3 randomized non-inferiority de-escalation trial found that cetuximab (cet) didn t have fewer side effects than cisplatin (cis) but cis-radiotherapy (cis-rt) worked better than cet-rt for people with hpv positive oropharyngeal cancer. #esmo2022
Flagship #OpenAccess medical journal from @BioMedCentral. Publishes research articles & reviews in all areas of research & practice in #medicine & #globalhealth